Latest Evista news
Raloxifene Does Not Appear to Boost Cognition in Alzheimer’s
posted November 5th
by modernClinician Editorial Team
by modernClinician Editorial Team
Raloxifene doesn't benefit cognition in women who have mild to moderate dementia due to Alzheimer's disease, according to a small study published online Nov. 4 in Neurology.
Editor's Recommendations
More Extensive Deposits of Tau Seen in Early-Onset Alzheimer Disease 
NOACs Linked to Slower Cognitive Decline in Patients With A-Fib, Alzheimer Disease 
Cortical Atrophy in Early-Onset Alzheimer Disease Signature Can Predict Progression to Dementia 
Exercise Link to Dementia Varies by Physical Activity Domain 
CTE Pathology Found in Nearly 75 Percent of Deceased Former NFL Players 
Insomnia Linked to Increased Risk for Stroke, Odds of Admission 
Increased Dementia Risk Seen After Transient Ischemic Attack 
Nearly 3 in 4 Older Adults Express Interest in Vaccine to Prevent Dementia Monthly Specialist Briefings
Stay Connected
